Digital Health Global

SEPTEMBER 28, 2023

Investments will focus on the next generation of pharma R&D to accelerate drug development, on new technology solutions enabling a more patient-centric approach in clinical trials, and on digital platforms uncovering new insights from clinical data for more personalized care pathways.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Life Science 88

Digital Health Global

JANUARY 31, 2024

In a large, bi-annual survey on patient experiences with clinical research, use of electronic consent forms (on an iPad, tablet, or other device) increased from 24% in 2019 to 44% in 2021, dipping slightly in 2023 to 32%. Medable, which ranked in the top 8% of software companies on the 2023 Inc. in Phase 3.

Health science 88

Health science Drug Development Digital Health Patient Experience 88

Society for Participatory Medicine

JANUARY 27, 2022

But returning to Erin Moore’s point, how do we get researchers, clinicians, and industry engaged to listen to patients in clinical trial design, pharma/biotech drug development and health tech capability? She was the patient keynote speaker at DPHARM 2021 and is a HIMSS Digital Health Influencer.

BioTech 107

BioTech Life Science Drug Development Patient Experience 107

Healthcare IT Today

JUNE 26, 2022

Care coordination network CarePort released its 2021 growth numbers. In addition, the company’s CarePort Referral Management product enabled nearly 25 million referrals in 2021. The Office of the National Coordinator for Health IT has some money for you. Partnerships.

Drug Development 82

Drug Development Healthcare IT Health IT EHR 82

Xealth

JUNE 27, 2023

Its interest in DTx exists specifically in remote patient monitoring because of the potential to provide valuable insights throughout drug development life cycles. Big Pharma is driving much of the speculation. Several big players have joined the DTA, which doubled in membership in 2022. They include Astellas Pharma Inc.,

Digital Health 52

Digital Health Drug Development Pharmaceuticals EHR 52

Lloyd Price

DECEMBER 11, 2023

Transforming healthcare A report from the London School of Economics, The Role of Virtual Health Care and the Pharmaceutical Sector in Improving Population Health , published in 2021, forecast that the pharmaceutical industry would be a core player in all aspects from population health management to preventive and therapeutic care.

Pharmaceuticals 63

Pharmaceuticals Digital Health Drug Development Life Science 63

Lloyd Price

FEBRUARY 18, 2024

Market Dynamics: Lower valuations: Compared to the heady days of 2021, HealthTech valuations have cooled down, making "soft landing" deals more attractive for both acquirers and targets. Pharmaceutical and Life Sciences Companies: These companies are looking for HealthTech solutions to: Enhance clinical trials and drug development processes.

Pharmaceuticals 63

Pharmaceuticals healthcare technology Digital Health Remote care 63

Lloyd Price

JUNE 17, 2023

2021: The integration of the two companies is underway. As the ability to collect and analyze large amounts of patient data grows, there is a growing opportunity for companies to develop personalized treatments and care plans. This could create a company that is able to develop and deliver personalized treatments to patients.

Digital Health 80

Digital Health Drug Development Telemedicine Telehealth 80

Healthcare IT Today

DECEMBER 27, 2022

Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development. “A

Pharmaceuticals 59

Pharmaceuticals Drug Development Medical Technology Healthcare IT 59

DrKumo Remote Patient Monitoring

APRIL 12, 2022

Though the drug metformin (a biguanide formed by the fusion of two guanidines) was developed in 1922 by Wermer and Bell, it was the efforts of the French physician Jean Sterne that paved the way for the use of metformin as a glucose-lowering drug. Sci Rep 11, 9240 (2021). Tarry-Adkins, J.L., Ozanne, S.E. &

Drug Development 97

Drug Development 97

Waracle

JANUARY 5, 2022

2021 has been a historic year for healthcare… and technology has been a crucial piece of the puzzle when it comes to keeping the healthcare industry resilient in the face of the challenges it has seen. . But that was 2021, what about the new year.? Here are some of our predictions for 2022. Using more wearables and connected devices.

Patient Experience 36

Patient Experience Drug Development Digital Health Remote care 36

Lloyd Price

FEBRUARY 22, 2024

In 2021, only 1.3% Reasons for Low Investment: High regulatory hurdles: Drug development for pain is historically challenging with a high failure rate due to complex pain mechanisms and stringent regulatory requirements. billion for oncology.

Pain management 56

Pain management Mental health Telehealth healthcare technology 56

Insulin Nation

FEBRUARY 14, 2019

C-Path forms and leads consortiums that include drug developers, academics, patient advocates and regulators to share data, knowledge, and expertise, resulting in sound, consensus-based science. The submission of these final documents is planned for 2021 contingent on the length of the regulatory review process. — [link].

Drug Development 13

Drug Development 13